EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Parkin activates innate immunity and promotes antitumor immune responses

Michela Perego, Minjeong Yeon, Ekta Agarwal, Andrew T Milcarek, Irene Bertolini, Chiara Camisaschi, Jagadish C Ghosh, Hsin-Yao Tang, Nathalie Grandvaux, Marcus Ruscetti, Andrew V Kossenkov, Sarah Preston-Alp und 3 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci180983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Michela Perego und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Immunity, Innate, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NLM NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of innate immunity and associated interferon (IFN) signaling have been implicated in cancer, but the regulators are elusive and links to tumor suppression remain undetermined. Here, we found that Parkin, an E3 ubiquitin ligase altered in Parkinson’s Disease, was epigenetically silenced in cancer and its reexpression by clinically approved demethylating therapy stimulated transcription of a potent IFN response in tumor cells. This pathway required Parkin E3 ubiquitin ligase activity, involved the subcellular trafficking and release of the alarmin High Mobility Group Box 1 (HMGB1) and was associated with inhibition of NF-κB gene expression. In turn, Parkin-expressing cells released an IFN secretome that upregulated effector and cytotoxic CD8 + T cell markers, lowered the expression of immune inhibitory receptors TIM3 and LAG3, and stimulated high content of the self renewal/stem cell factor, TCF1. PRKN-induced CD8 + T cells selectively accumulated in the microenvironment and inhibited transgenic and syngeneic tumor growth in vivo. Therefore, Parkin is an epigenetically regulated activator of innate immunity and dual mode tumor suppressor, inhibiting intrinsic tumor traits of metabolism and cell invasion, while simultaneously reinvigorating CD8 T cell functions in the microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesImmunity, InnateCD8-Positive T-LymphocytesAnimalsHumansMiceHMGB1 ProteinCell Line, TumorInterferonsNF-kappa BTumor MicroenvironmentNeoplasmsMice, TransgenicMice, Inbred C57BL

Stichwörter der Autor:innen

ImmunologyInnate immunityMitochondriaOncologyTumor suppressors

Substanzen

Ubiquitin-Protein Ligasesparkin proteinHMGB1 ProteinInterferonsHMGB1 protein, humanNF-kappa B

Autor:innen und Institutionen

  • Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
  • Flow Cytometry Core, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Center for Systems and Computational Biology and.
  • Proteomics and Metabolomics Shared Resource, The Wistar Institute, Philadelphia, Pennsylvania, USA.
  • CRCHUM - Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NLM NIH HHS
  • National Institutes of Health

Zitieren

APA

Perego, M., Yeon, M., Agarwal, E., Milcarek, A. T., Bertolini, I., Camisaschi, C., Ghosh, J. C., Tang, H. Y., Grandvaux, N., Ruscetti, M., Kossenkov, A. V., Preston-Alp, S., Tempera, I., Auslander, N., & Altieri, D. C. (2024). Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. https://doi.org/10.1172/jci180983

Vancouver

Perego M, Yeon M, Agarwal E, Milcarek AT, Bertolini I, Camisaschi C, et al. Parkin activates innate immunity and promotes antitumor immune responses. Journal of Clinical Investigation. 2024. doi:10.1172/jci180983

BibTeX
@article{Perego2024,
  author = {Perego, Michela and Yeon, Minjeong and Agarwal, Ekta and Milcarek, Andrew T and Bertolini, Irene and Camisaschi, Chiara and Ghosh, Jagadish C and Tang, Hsin-Yao and Grandvaux, Nathalie and Ruscetti, Marcus and Kossenkov, Andrew V and Preston-Alp, Sarah and Tempera, Italo and Auslander, Noam and Altieri, Dario C},
  title = {Parkin activates innate immunity and promotes antitumor immune responses},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci180983}
}
Kostenlos starten →